stocks Perrigo Corporation Limited

  • Steven A. Cohen, Founder and CEO of SAC Capital.

    Internal trading records raise questions on whether the government will be able to build a case against Steven A. Cohen, the billionaire owner of the hedge fund.

  • SAC Capital Advisors expects client withdrawals of at least $1 billion in 2013 as the hedge fund battles intense regulatory scrutiny over insider trading allegations, the Wall Street Journal said on Friday, citing people briefed on the matter.

  • Elan Corp. PLC reported a third-quarter loss Wednesday, as heavy charges tied to a business spinoff and the discontinuation of an Alzheimer's drug study weighed on the Irish drugmaker's performance.

  • In a story Oct. 16 on Johnson& Johnson's third-quarter results, The Associated Press reported that J&J would take a $340 million charge for ending testing of the intravenous form of Alzheimer's disease drug bapineuzumab and said that J&J's partner, Pfizer Inc., would be taking a similar charge.

  • DUBLIN, Oct 9- Elan Corporation PLC:. *Received tenders and consents of $439.5 million aggregate principal amount of. *And $141.3 million aggregate principal amount of 2010 notes or 92.69%.

  • MILAN, Oct 3- The troubled Italian smelter of aluminium group Alcoa will be able to continue using special contracts allowing it to buy electricity at lower prices until 2015 following a decision on Wednesday by the European Commission.

  • MILAN, Oct 3- The troubled Italian smelter of aluminium group Alcoa will be able to continue using special contracts allowing it to buy electricity at lower prices until 2015 following a decision on Wednesday by the European Commission. Alcoa has decided to shut its aluminium smelter in Sardinia, blaming high power prices for undermining its competitiveness.

  • MILAN, Oct 3- The European Commission said on Wednesday interruptibility contracts in Sardinia and Sicily allowing companies to pay less for their electricity do not constitute state aid. In a statement, the Commission said it had authorised an extension for the use of such contracts until 2015..

  • Oct 1- Elan Corporation PLC:. *Says notes in an aggregate principal amount of $624.5 million are currently. *Says the redemption is expected to occur on October 31, 2012.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Wednesday morning's early movers:

  • The Irish company will issue its quarterly results at a difficult time for its public image. Elan has been busy with damage control, first when its Tysabri multiple schlerosis drug was linked to brain infections and then when it retained part ownership in its corporate jet after firing 10 percent of its workforce.

  • Stocks trimmed losses in the final hour of trading to end flat amid mixed earnings and economic news, and ahead of the President's State of the Union speech tonight.  AmEx and Bank of America fell, while Wal-Mart rose.

  • Stocks trimmed losses but remained down as technology stocks turned around following a handful of weak earnings reports from major Dow components and on the heels of mixed economic news, and ahead of the President's State of the Union speech tonight.

  • Stocks ended mixed after trading in a narrow range most of the session amid light volume Monday, as investors considered Federal Reserve Chairman Ben Bernanke's comments about additional Fed stimulus and regrouped after strong gains in the market last week. Cisco and Pfizer rose, while BofA fell.

  • Stocks moved in a narrow range amid light volume Monday, and were ending the session mixed as investors considered Federal Reserve Chairman Ben Bernanke's comments about additional Fed stimulus and regrouped after strong gains in the market last week.  BofA and Cocoa-Cola fell, while Cisco rose.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Cramer makes the call on viewers' favorite stocks.

  • acorda_logo_200.jpg

    Thirteen-grand a year. That's about how much Acorda Therapeutics says it'll charge for its newly approved drug Ampyra for multiple sclerosis.

  • Cramer makes the call on viewers' favorite stocks.